Moderna MRNA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.23B-30.0% | $1.94B-39.9% | $2.23B-56.1% | $3.08B-39.0% | $3.18B-38.3% | ||
| $1.73B+18.9% | $868M-40.7% | $1.16B-30.2% | $1.46B-56.8% | $1.46B-63.5% | ||
| $492M-71.4% | $1.08B-39.3% | $1.08B-68.6% | $1.62B-3.2% | $1.72B+48.7% | ||
| 22.1%-32.0pp | 55.3%+0.6pp | 48.3%-19.2pp | 52.5%+19.5pp | 54.1%+31.7pp | ||
| $2.93B-32.5% | $3.13B-31.1% | $3.48B-27.9% | $3.82B-21.3% | $4.34B-9.2% | ||
| $979M-12.0% | $1.02B-13.3% | $1.06B-17.9% | $1.07B-26.1% | $1.11B-26.7% | ||
| $5.64B-18.4% | $5.02B-30.1% | $5.7B-26.7% | $6.35B-34.4% | $6.91B-32.9% | ||
| -$3.41B+8.5% | -$3.07B+22.1% | -$3.46B-28.3% | -$3.27B+29.5% | -$3.73B+27.5% | ||
| -153.3%-36.0pp | -158.1%-36.2pp | -155.2%-102pp | -106.3%-14.4pp | -117.4%-17.5pp | ||
| -$22M+69.4% | -$8M+90.8% | -$25M+74.2% | -$37M+72.8% | -$72M+24.2% | ||
| -$3.14B+7.9% | -$2.77B+23.3% | -$3.15B-30.1% | -$2.95B+33.1% | -$3.41B+30.1% | ||
| $56M+214% | $54M+217% | -$37M— | -$42M— | -$49M— | ||
| -$3.19B+4.9% | -$2.82B+20.8% | -$3.12B-27.7% | -$2.9B+52.3% | -$3.36B+45.7% | ||
| -143.6%-37.9pp | -145.2%-35.1pp | -139.6%-91.6pp | -94.3%+26.2pp | -105.7%+14.4pp | ||
| -$8.15+6.6% | -$7.27+21.7% | -$8.07-26.7% | -$7.53+52.7% | -$8.73+46.2% | ||
| -$3.18B+10.2% | -$2.86B+23.9% | -$3.26B-37.5% | -$3.07B+25.5% | -$3.54B+22.5% | ||
| -142.8%-31.5pp | -147.1%-31.0pp | -145.8%-99.2pp | -99.6%-18.1pp | -111.3%-22.7pp | ||
| -$3.41B+8.5% | -$3.07B+22.1% | -$3.46B-28.3% | -$3.27B+29.5% | -$3.73B+27.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Moderna's revenue?
- Moderna (MRNA) generated $2.2B in revenue over the trailing twelve months, down 30.0% year over year.
- Is Moderna profitable?
- Moderna is not currently profitable: it reported a net loss of $3.2B over the trailing twelve months, a -143.6% net margin.
- What are Moderna's profit margins?
- Gross margin is 22.1% and operating margin is -153.3%, with a -143.6% net margin.
- What is Moderna's earnings per share?
- Moderna's diluted EPS over the trailing twelve months is $-8.15.
- Where does Moderna's income statement data come from?
- Every line is extracted from Moderna's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
